Re-analysis of public datasets consistently highlights immune-regulatory pathways—such as IL-23/Th17, NF-κB, and cytokine signaling—as central features across IBD subtypes, reaffirming their pivotal role in disease pathogenesis. This evidence concerns the gene NFKB1 and inflammatory bowel disease.